Orapharma Inc
Bridgewater, US · 5 known investors
Find your way into Orapharma Inc
Sign up to find every way you can get introduced to Orapharma Inc
- Your email: who you already know at Orapharma Inc, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Orapharma Inc team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
OraPharma develops pharmaceutical products and tools for dental professionals to address oral health concerns, serving dental practices and patients. The company provides educational resources and partners with dental service organizations and academic institutions.
Investors · 5
Canaan Partnerslisted by Canaan PartnersStamford · $500K – $20M
How we know: Canaan Partners's portfolio page · Not right? Tell us
Related companies · 2
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
1MgThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.
Companies working in the same space as Orapharma Inc.
Frequently asked questions
- What does Orapharma Inc do?
- OraPharma develops pharmaceutical products and tools for dental professionals to address oral health concerns, serving dental practices and patients. The company provides educational resources and partners with dental service organizations and academic institutions.
- Who are Orapharma Inc's investors?
- Orapharma Inc's investors include A-Rod Corp, Canaan Partners, Frazier Life Sciences, HealthCap, Oak Investment Partners.
- Where is Orapharma Inc headquartered?
- Orapharma Inc is headquartered in Bridgewater, US.

